Showing results (31-40 of 281) with videos related to
Sort By:
Pageof 29
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1990
Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamilyM V Relling, T Aoyama, F J Gonzalez, et al.Clinical Pharmacology and Therapeutics|November 6, 2015
Integrated patient and tumor genetic testing for individualized cancer therapyD L Hertz, H L McLeodCancer Surveys|January 1, 1993
Clinical pharmacokinetics and pharmacodynamics of epipodophyllotoxinsH L McLeod, W E EvansPediatrics in Review|November 1, 1992
Pediatric pharmacokinetics and therapeutic drug monitoringH L McLeod, W E EvansCurrent Medicinal Chemistry|February 7, 2003
Lessons learned from the irinotecan metabolic pathwayM K Ma, H L McLeodBritish Journal of Cancer|August 1, 1996
Variation in topoisomerase I gene copy number as a mechanism for intrinsic drug sensitivityH L McLeod, W N KeithAnnual Review of Pharmacology and Toxicology|March 27, 2001
Pharmacogenomics: unlocking the human genome for better drug therapyH L McLeod, W E EvansClinical Pharmacology and Therapeutics|November 18, 2011
PON1 Q192R and clopidogrel: a case of the winner's curse or inadequate replication?J A Talameh, H L McLeodClinical Pharmacology and Therapeutics|August 6, 2008
Harnessing economic drivers for successful clinical implementation of pharmacogenetic testingP A Deverka, H L McLeodClinical Pharmacology and Therapeutics|September 21, 2012
Ready when you are: easing into preemptive pharmacogeneticsY J He, H L McLeodPageof 29